Sun Pharmaceutical Industries Share Price Today - Live Blog for June 17, 2025

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.16% gain, with the share price now at ₹1,653.55. Notably, the stock's PE ratio stands at 37.0000, and its Return on Equity (ROE) is 15.1334%.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.03% increase and currently trading at ₹1,650.90 per share. This upward trajectory is turning heads in the market.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.20% slump and is currently trading at ₹1,642.10. While the stock maintains a PE ratio of 37.0000, the industry PE is 34.8804, raising questions about valuation.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.20%, a situation worth noting. At present, the stock is trading at ₹1,642.10. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 37.0000, while the industry PE ratio is 34.8804.

Sun Pharmaceutical Industries Ltd shares saw a -0.62% decrease, reaching a current market price of ₹1,644.50. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.0000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.02%, and it is currently trading at ₹1,654.15. Additionally, the stock maintains a PE ratio of 37.0000, while the industry PE is 34.8804.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.06%, a development that warrants careful analysis. Presently trading at ₹1,653.85, investors are assessing whether this presents an opportunity or a risk.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.15% boost, with the current market value at ₹1,655.15 per share. This surge has not gone unnoticed by investors.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.05%, with its current market value per share resting at ₹1,652.90. This development highlights the stock's appeal to investors.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.11% decline and is currently trading at ₹1,651.75 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.24% increase and currently trading at ₹1,652.70 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd shares saw a -0.03% decrease, reaching a current market price of ₹1,647.15. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.0000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.20%, signalling a challenging period. Currently trading at ₹1,646.65, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.05%, a situation worth noting. At present, the stock is trading at ₹1,649.20. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 37.0000, while the industry PE ratio is 34.8804.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.17% decline, and it currently trades at ₹1,650.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd share price has declined by -0.01%, and it's currently trading at ₹1,652.65. The stock maintains a PE of 37.0000, while the industry PE is 34.8804, prompting discussions about its valuation.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.06% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,652.05 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.09%, signalling a challenging period. Currently trading at ₹1,650.40, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.02%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,651.00 per share.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.08%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,650.65, and market participants are assessing the implications. The stock has a PE ratio of 37.0000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.08%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,652.35, and market participants are assessing the implications. The stock has a PE ratio of 37.0000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.02%, reaching the current market value of ₹1,653.25 per share. This surge is a testament to the stock's recent performance.

With a -0.23% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,652.50. Investors should examine the factors driving this decline. The stock's PE ratio is 37.0000, whereas the industry PE ratio stands at 34.8804.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.42%, reaching a current market price of ₹1,656.55. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.19%, with the current market value at ₹1,663.65 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd stock price decreased by -1.94%, with the current market value at ₹1,666.90 per share. Investors are assessing the stock's potential for recovery and future growth prospects.